All Type of News
Domestic Guidance on Celecoxib, Naproxen Released
The Korea Food and Drug Administration (KFDA) released its pharmaceutical safety memorandum addressed to the healthcare professionals and to the general public, citing its current effort in reviewing the safety issues...
Kolmar Introduced Treatment for Atopic Dermatitis
Following the Korea Food and Drug Administration (KFDA)’s recent approval on pharmaceutical bioequivalence of the generic drugs, Korea Kolmar announced its successful development of a medication for treatment of atopi...
KAPW Seeks Improved Margin and Collateral Considerations from Pharmaceutical Manufacturers
In his new year message, the Korea Association of Pharmaceutical Wholesaler (KAPW) Chairman Ju Man-gil made a number of suggestions to the pharmaceutical manufacturing industry and to the government, in an effort to i...
Increasing Number of Biopharmaceutical Products Qualified with National Standards
A total number of biopharmaceutical products that are qualified under the national standards has now increased to 13 items, according to a recent announcement by the Korea Food and Drug Administration (KFDA).
A n...
One-Call, Total-Service Based KFDA Call Center Now Operational
The Korea Food and Drug Administration has recently announced its launching of the total service call center, effective December 23rd, in order to realize a higher level of efficiency in dealing with over 200,000 civi...
Competition among Manufacturers of Cold Medicines Intensifies
As the temperature plunges under its freezing level, there is a fierce competition among the pharmaceutical manufacturers of cold medicines to win their shares of seasonal demand in the market, and this drives the ove...
KFDA Takes Detailed Safety Review on Celebrex
The Korea Food and Drug Administration (KFDA) announced that it is taking a detailed safety review on Pfizer’s Celebrex, reflecting the U.S. Food and Drug Administration (FDA)’s recent citation on the safety issues of...
Significant Pharmacy Retail Prices for OTC Products Discovered
The Ministry of Health and Welfare (MOHW) conducted a study of retail price comparisons and differences on 48 pharmaceutical OTC products that are classified as the most frequently purchased items by the consumers, an...
SK Chemical Officially Announces Its Merger Plan with SK Pharma
SK Chemical announced on December 23 that the company has declared an official merger plan with SK Pharma, via signing a contract with Samil PriceWaterhouseCoopers (PWC), a domestic affiliate of the international acco...
Domestic Ban on Sale of Celebrex Suggested by Pharmacist Group
In an official statement released on December 21st, the Korean Pharmacists for Democratic Society (KPDS) strongly suggested that Pfizer should withdraw Celebrex, a Cox-2 inhibitor for treatment of pain and inflammatio...
